Eli Lilly and Company (LLYC)
Healthcare • Drug Manufacturers - General
StockViennaUnited StatesES0105591004
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Eli Lilly and Company, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in EUR. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 13:56. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 01:00 | 11.23 | — | — | Upcoming |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 65.2B | +44.7% | 20.6B | 31.7% | 22.95 | +96.0% | 6B |
| 2024 | 45B | +32.0% | 10.6B | 23.5% | 11.71 | +101.9% | 414M |
| 2023 | 34.1B | +19.6% | 5.2B | 15.4% | 5.80 | -11.7% | -3.2B |
| 2022 | 28.5B | — | 6.2B | 21.9% | 6.57 | — | 4.6B |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 1,265.60 | 1,303.80 | 1,202.80 | 1,292.80 | +1.38% | 3 | 1.5651 |
| Oct 2026 | 1,024.20 | 1,277.40 | 1,017.40 | 1,275.20 | +21.59% | 73 | |
| Sep 2026 | 998.00 | 1,049.20 | 962.30 | 1,048.80 | +5.27% | 660 | |
| Aug 2026 | 1,002.00 | 1,095.00 | 967.40 | 996.30 | +0.27% | 904 | 1.5651 |
| Jul 2026 | 1,051.20 | 1,085.40 | 992.00 | 993.60 | -6.26% | 1,841 | |
| Jun 2026 | 940.10 | 1,084.80 | 913.50 | 1,060.00 | +13.28% | 2,840 | |
| May 2026 | 823.00 | 969.40 | 799.60 | 935.70 | +18.99% | 622 | 1.5651 |
| Apr 2026 | 798.30 | 826.90 | 730.00 | 786.40 | -0.64% | 673 | |
| Mar 2026 | 883.10 | 898.60 | 767.80 | 791.50 | -9.38% | 1,054 | |
| Feb 2026 | 872.90 | 940.20 | 845.90 | 873.40 | +0.26% | 1,129 | 1.5651 |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in EUR, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- State Street Health Care SPDR (XLV) Adds Eli Lilly and Johnson & Johnson on Nov. 10 (opens in a new tab) GuruFocus.com · 12 Nov 2026 11:05
- Eli Lilly and Company (LLY) Grew Revenue 48% as GLP-1 Demand Accelerated: Can Growth Continue? (opens in a new tab) Insider Monkey · 10 Nov 2026 15:59
- The FDA Ordered GLP-1 Vision-Loss Warnings For Some Products. Shares of Eli Lilly and Novo Nordisk Were Unfazed. (opens in a new tab) International Business Times · 10 Nov 2026 12:41
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 1,283.20 EUR
- Market cap
- 1.2T
- Dividend yield
- 0.48%
- 5-year average yield
- 0.75%
- Payout ratio
- 22%
- Last dividend
- 1.7300 EUR · 13 Nov 2026
- Next ex-dividend date
- 13 Nov 2026
- Exchange
- Vienna
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
Dividends
| Ex-dividend date | Per share |
|---|---|
| 13 Nov 2026 | 1.5651 EUR |
| 14 Aug 2026 | 1.5651 EUR |
| 15 May 2026 | 1.5651 EUR |
| 13 Feb 2026 | 1.5651 EUR |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow LLYC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.